29 closest matches · ranked by relevance
Glaucoma · Retinal Disease · Strabismus
Primary: Total Examination Time — 728.6; 676.7; 707.6; 620.6 seconds
Diabetes Mellitus
Primary: Overall User Preference for the FreeStyle InsuLinx System Compared to Current Method. — 125 participants — p=<0.0001
Vision Disorders
Primary: Score of System Usability Scale (SUS) Questionnaire — 76.7 score on a scale
Sars-CoV-2 Infection · COVID-19
Primary: 30 Candidate Ag Test Self-collections — 53; 0 Participants
Chronic Kidney Failure
Primary: Ease of Use: Priming Blood Side — 139; 13; 13; 80 Number of Dialyzers
Onychomycosis
Primary: Human Factors — 15 participants
Multiple Sclerosis
Primary: The Primary Endpoint is the Proportion of RMS Subjects Rating the RebiSmart™ Autoinjector as 'Easy to Use' or 'Very Easy to Use' for Self-injection in a User Trial…
Wrinkles
Primary: Usability Assessment — 25 Participants
Nasal Congestion · Respiratory Tract Infection · Sinusitis
Primary: Number of Participants Who Properly Used the Nasal Irrigator/Aspirator Device — 29 participants — p=0.0005
Multiple Sclerosis · Pain · Fatigue Symptom
Primary: Participant Perception of Me Time MS App Usability — 37; 11; 9; 4 Comments
Hearing Loss
Primary: Patient Satisfaction Through Usability of the CP950 Sound Processor as Measured by the CP950 Take Home Questionnaire — 22; 28; 27; 28 Participants
Erectile Dysfunction
Primary: Percentage of Participants Who Successfully Operated the Caverject Impulse Delivery System — 95.83 percentage of participants
Healthy
Primary: Delivery System Success Rate (DSSR) — 66.67; 66.67; 100.00; 100.00 percentage of participants
Growth Disorders
Primary: Subjects' Overall Impression After Using E-Device — 0; 7; 13 subjects
Diabetic Foot Ulcers
Primary: Ease of Use Assessment — 0; 3; 14; 13 Participants
Atopic Dermatitis
Primary: Percentage of Participants Who Responded Agree or Strongly Agree to the 'Overall Ease of Use' Question Using the Modified Subcutaneous Administration Assessment…
Diabetes Mellitus
Primary: Enhanced Meter Feature Usability — 50 Participants
Ease of Use
Primary: Percentage of Nights' Data That Were Successfully Recorded — 79; 86; 100 percentage of nights' data
Growth Hormone Disorder · Growth Hormone Deficiency in Children · Foetal Growth Problem
Primary: The Relative Ease of Use of NordiFlex® Compared to the Device Previously Used — 6.89 units on a scale
Refractive Error
Primary: Subjective Ease of Lens Removal — 45; 76; 23; 34 participants
Diabetes
Primary: Percentage of Participants Rated as <=3 (Comprehension of Labeling) — 100; 100; 100; 100 percentage of participants
Multiple Sclerosis
Primary: Proportion of Relapsing Multiple Sclerosis (RMS) Subjects Rating the Single-use Autoinjector as 'Easy to Use' or 'Very Easy to Use' for Self-injection in a User Trial…
Chronic Venous Insufficiency
Primary: Ease of Use and Comfort for Subjects Using the ACTitouch System. — 70.8; 37.5; 89.2; 59.4 Percent of participants
Chronic Kidney Disease
Primary: Comparison of Urea Removal Under Conditions of Routine Hemodialysis. — 1.64; 1.61; 1.42; 1.40 ratio
Diabetes Mellitus, Type 2
Primary: Usability — 78.8 score on a scale — p=<0.001
Laparoscopy
Primary: Investigators Assessment of Tachosil — 1.91; 1.86 score on a scale
Hearing Loss, Sensorineural · Hearing Loss, Bilateral
Primary: Number of Participants Who While Using the Final Version of Remote Assist, Are Able to Complete the Primary Tasks (Score of 5 on the Usability Rating Scale) — 13…
Growth Hormone Deficiency
Primary: Percent rhGH Injections Missed During the Treatment Period (Based on the Easypod™ Injection Log) — 20; 19.46; 20 Percent of injections missed — p=0.908
Asthma · Chronic Obstructive Pulmonary Disease · Interstitial Lung Disease
Primary: System Usability Scale — 57.92; 61.68 score on a scale